2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide, published by CDC / Security Risk Solutions, Inc. (SRS). This guide is not an authorized publication; it is the continuous build for version 2022.1.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/security-rs/opioid-cds-r4/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

ValueSet: Opiate specific urine drug screening tests

Official URL: http://fhir.org/guides/cdc/opioid-cds/ValueSet/opiate-specific-urine-drug-screening-tests				Version: 2022.1.1
Active as of 2026-05-01				Computable Name: OPIATE_SPECIFIC_URINE_DRUG_SCREENING_TESTS
Other Identifiers: OID:2.16.840.1.114222.48.27
Copyright/Legal: © CDC 2016+.

Urine tests for naturally occurring opioids (i.e. opiates) that are specific to a particular naturally occurring opioid and therefore do not have the general word ‘opiates’ in the long name.

Identification of urine drug tests where results can be used when considering pain management therapy

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

 

Expansion

---

Explanation of the columns that may appear on this page:

Level	A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System	The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code	The code (used as the code in the resource instance)
Display	The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition	An explanation of the meaning of the concept
Comments	Additional notes about how to use the code